Considerations for Quality Evaluation in the Marketing Authorization Application of Recombinant Adeno-Associated Virus Vector-Based Medicinal Products

Lu Jiaqi; Yang Fei; Jia Dongchen; Wang Xue; Wang Wenbo; Wei Wei

doi:10.16153/j.1002-7777.2026-07-0032

Lu Jiaqi, Yang Fei, Jia Dongchen, Wang Xue, Wang Wenbo, Wei Wei

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (9) : 1035-1045.

PDF(1001 KB)

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (9) : 1035-1045. DOI: 10.16153/j.1002-7777.2026-07-0032

Assessment Techniques & Guidance: Special Column on Technical Assessment of Biologics

Considerations for Quality Evaluation in the Marketing Authorization Application of Recombinant Adeno-Associated Virus Vector-Based Medicinal Products

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 40(9): 1035-1045 https://doi.org/10.16153/j.1002-7777.2026-07-0032

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1001 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2026-07-20	2026-09-20
Issue Date
2026-10-09

Please choose a citation manager

Content to export